famotidine has been researched along with Exanthema in 2 studies
Famotidine: A competitive histamine H2-receptor antagonist. Its main pharmacodynamic effect is the inhibition of gastric secretion.
Exanthema: Diseases in which skin eruptions or rashes are a prominent manifestation. Classically, six such diseases were described with similar rashes; they were numbered in the order in which they were reported. Only the fourth (Duke's disease), fifth (ERYTHEMA INFECTIOSUM), and sixth (EXANTHEMA SUBITUM) numeric designations survive as occasional synonyms in current terminology.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Salehi, M | 1 |
| Khalili, H | 1 |
| Jahani, Z | 1 |
| Rasoolinejad, M | 1 |
| Ghiasvanad, F | 1 |
| Scheinfeld, N | 1 |
| Wesson, K | 1 |
| Perry, P | 1 |
| Weinberg, J | 1 |
2 other studies available for famotidine and Exanthema
| Article | Year |
|---|---|
Famotidine's Possible Cutaneous Rash in COVID-19 Patients: An Adverse Effect Case Series.
Topics: COVID-19 Drug Treatment; Exanthema; Famotidine; Female; Humans; Male; Middle Aged; SARS-CoV-2; Skin | 2022 |
Acute generalized exanthematous pustulosis resembling toxic epidermal necrolysis caused by famotidine.
Topics: Diagnosis, Differential; Drug Eruptions; Exanthema; Famotidine; Female; Histamine H2 Antagonists; Hu | 2003 |